APO RESEARCH · REPORT
Ursodeoxycholic Acid
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Product & engineering
Understand the product.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Selected research
Market Structure
Global Ursodeoxycholic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
Global Ursodeoxycholic Acid key players include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Dipharma Francis, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Synthetic UDCA is the largest segment, with a share about 95%. And in terms of application, the largest application is Pharmacy, followed by Health Products.
This report provides an overview of the global Ursodeoxycholic Acid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Ursodeoxycholic Acid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ursodeoxycholic Acid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ursodeoxycholic Acid market size, projected growth trends, production technologies, key applications, and end-use industries.
Ursodeoxycholic Acid Segment by Company
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan belling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Ursodeoxycholic Acid Segment by Type
Synthetic UDCA
Extraction UDCA
Ursodeoxycholic Acid Segment by Application
Pharmacy
Health Products
Ursodeoxycholic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ursodeoxycholic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ursodeoxycholic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ursodeoxycholic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ursodeoxycholic Acid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ursodeoxycholic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ursodeoxycholic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ursodeoxycholic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic UDCA
- Extraction UDCA
Applications
- Pharmacy
- Health Products
Companies covered
- ICE
- Mitsubishi Tanabe Pharma
- Daewoong Chemical
- PharmaZell GmbH
- Zhongshan belling
- Dipharma Francis
- Grindeks
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ursodeoxycholic Acid Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ursodeoxycholic Acid Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ursodeoxycholic Acid Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ursodeoxycholic Acid Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ursodeoxycholic Acid Market Dynamics
- 2.1 Ursodeoxycholic Acid Industry Trends
- 2.2 Ursodeoxycholic Acid Industry Drivers
- 2.3 Ursodeoxycholic Acid Industry Opportunities and Challenges
- 2.4 Ursodeoxycholic Acid Industry Restraints
3 Ursodeoxycholic Acid Market by Manufacturers
- 3.1 Global Ursodeoxycholic Acid Revenue by Manufacturers (2021-2026)
- 3.2 Global Ursodeoxycholic Acid Sales by Manufacturers (2021-2026)
- 3.3 Global Ursodeoxycholic Acid Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ursodeoxycholic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ursodeoxycholic Acid Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ursodeoxycholic Acid Manufacturers, Product Type & Application
- 3.7 Global Ursodeoxycholic Acid Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ursodeoxycholic Acid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ursodeoxycholic Acid Players Market Share by Revenue in 2025
- 3.8.3 2025 Ursodeoxycholic Acid Tier 1, Tier 2, and Tier 3
4 Ursodeoxycholic Acid Market by Type
- 4.1 Ursodeoxycholic Acid Type Introduction
- 4.1.1 Synthetic UDCA
- 4.1.2 Extraction UDCA
- 4.2 Global Ursodeoxycholic Acid Sales by Type
- 4.2.1 Global Ursodeoxycholic Acid Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ursodeoxycholic Acid Sales by Type (2021-2032)
- 4.2.3 Global Ursodeoxycholic Acid Sales Market Share by Type (2021-2032)
- 4.3 Global Ursodeoxycholic Acid Revenue by Type
- 4.3.1 Global Ursodeoxycholic Acid Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ursodeoxycholic Acid Revenue by Type (2021-2032)
- 4.3.3 Global Ursodeoxycholic Acid Revenue Market Share by Type (2021-2032)
5 Ursodeoxycholic Acid Market by Application
- 5.1 Ursodeoxycholic Acid Application Introduction
- 5.1.1 Pharmacy
- 5.1.2 Health Products
- 5.2 Global Ursodeoxycholic Acid Sales by Application
- 5.2.1 Global Ursodeoxycholic Acid Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ursodeoxycholic Acid Sales by Application (2021-2032)
- 5.2.3 Global Ursodeoxycholic Acid Sales Market Share by Application (2021-2032)
- 5.3 Global Ursodeoxycholic Acid Revenue by Application
- 5.3.1 Global Ursodeoxycholic Acid Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ursodeoxycholic Acid Revenue by Application (2021-2032)
- 5.3.3 Global Ursodeoxycholic Acid Revenue Market Share by Application (2021-2032)
6 Global Ursodeoxycholic Acid Sales by Region
- 6.1 Global Ursodeoxycholic Acid Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ursodeoxycholic Acid Sales by Region (2021-2032)
- 6.2.1 Global Ursodeoxycholic Acid Sales by Region (2021-2026)
- 6.2.2 Global Ursodeoxycholic Acid Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ursodeoxycholic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ursodeoxycholic Acid Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ursodeoxycholic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ursodeoxycholic Acid Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ursodeoxycholic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ursodeoxycholic Acid Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ursodeoxycholic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ursodeoxycholic Acid Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ursodeoxycholic Acid Revenue by Region
- 7.1 Global Ursodeoxycholic Acid Revenue by Region
- 7.1.1 Global Ursodeoxycholic Acid Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ursodeoxycholic Acid Revenue by Region (2021-2026)
- 7.1.3 Global Ursodeoxycholic Acid Revenue by Region (2027-2032)
- 7.1.4 Global Ursodeoxycholic Acid Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ursodeoxycholic Acid Revenue (2021-2032)
- 7.2.2 North America Ursodeoxycholic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ursodeoxycholic Acid Revenue (2021-2032)
- 7.3.2 Europe Ursodeoxycholic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ursodeoxycholic Acid Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ursodeoxycholic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ursodeoxycholic Acid Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ursodeoxycholic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ICE
- 8.1.1 ICE Company Information
- 8.1.2 ICE Business Overview
- 8.1.3 ICE Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ICE Ursodeoxycholic Acid Product Portfolio
- 8.1.5 ICE Recent Developments
- 8.2 Mitsubishi Tanabe Pharma
- 8.2.1 Mitsubishi Tanabe Pharma Company Information
- 8.2.2 Mitsubishi Tanabe Pharma Business Overview
- 8.2.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Product Portfolio
- 8.2.5 Mitsubishi Tanabe Pharma Recent Developments
- 8.3 Daewoong Chemical
- 8.3.1 Daewoong Chemical Company Information
- 8.3.2 Daewoong Chemical Business Overview
- 8.3.3 Daewoong Chemical Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Daewoong Chemical Ursodeoxycholic Acid Product Portfolio
- 8.3.5 Daewoong Chemical Recent Developments
- 8.4 PharmaZell GmbH
- 8.4.1 PharmaZell GmbH Company Information
- 8.4.2 PharmaZell GmbH Business Overview
- 8.4.3 PharmaZell GmbH Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 PharmaZell GmbH Ursodeoxycholic Acid Product Portfolio
- 8.4.5 PharmaZell GmbH Recent Developments
- 8.5 Zhongshan belling
- 8.5.1 Zhongshan belling Company Information
- 8.5.2 Zhongshan belling Business Overview
- 8.5.3 Zhongshan belling Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zhongshan belling Ursodeoxycholic Acid Product Portfolio
- 8.5.5 Zhongshan belling Recent Developments
- 8.6 Dipharma Francis
- 8.6.1 Dipharma Francis Company Information
- 8.6.2 Dipharma Francis Business Overview
- 8.6.3 Dipharma Francis Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Dipharma Francis Ursodeoxycholic Acid Product Portfolio
- 8.6.5 Dipharma Francis Recent Developments
- 8.7 Grindeks
- 8.7.1 Grindeks Company Information
- 8.7.2 Grindeks Business Overview
- 8.7.3 Grindeks Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Grindeks Ursodeoxycholic Acid Product Portfolio
- 8.7.5 Grindeks Recent Developments
- 8.8 Erregierre
- 8.8.1 Erregierre Company Information
- 8.8.2 Erregierre Business Overview
- 8.8.3 Erregierre Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Erregierre Ursodeoxycholic Acid Product Portfolio
- 8.8.5 Erregierre Recent Developments
- 8.9 Abil Chempharma
- 8.9.1 Abil Chempharma Company Information
- 8.9.2 Abil Chempharma Business Overview
- 8.9.3 Abil Chempharma Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Abil Chempharma Ursodeoxycholic Acid Product Portfolio
- 8.9.5 Abil Chempharma Recent Developments
- 8.10 Biotavia Labs
- 8.10.1 Biotavia Labs Company Information
- 8.10.2 Biotavia Labs Business Overview
- 8.10.3 Biotavia Labs Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Biotavia Labs Ursodeoxycholic Acid Product Portfolio
- 8.10.5 Biotavia Labs Recent Developments
- 8.11 Suzhou Tianlu
- 8.11.1 Suzhou Tianlu Company Information
- 8.11.2 Suzhou Tianlu Business Overview
- 8.11.3 Suzhou Tianlu Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Suzhou Tianlu Ursodeoxycholic Acid Product Portfolio
- 8.11.5 Suzhou Tianlu Recent Developments
- 8.12 Arcelor Chemicals
- 8.12.1 Arcelor Chemicals Company Information
- 8.12.2 Arcelor Chemicals Business Overview
- 8.12.3 Arcelor Chemicals Ursodeoxycholic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Arcelor Chemicals Ursodeoxycholic Acid Product Portfolio
- 8.12.5 Arcelor Chemicals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ursodeoxycholic Acid Value Chain Analysis
- 9.1.1 Ursodeoxycholic Acid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ursodeoxycholic Acid Production Mode & Process
- 9.2 Ursodeoxycholic Acid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ursodeoxycholic Acid Distributors
- 9.2.3 Ursodeoxycholic Acid Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst